Revista do Hospital das Clinicas最新文献

{"title":"The best infertility treatment for vasectomized men: assisted reproduction or vasectomy reversal?","authors":"Fábio Firmbach Pasqualotto,&nbsp;Antônio Marmo Lucon,&nbsp;Bernardo Passos Sobreiro,&nbsp;Eleonora Bedin Pasqualotto,&nbsp;Sami Arap","doi":"10.1590/s0041-87812004000500016","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500016","url":null,"abstract":"<p><p>In men with prior vasectomy, microsurgical reconstruction of the reproductive tract is more cost-effective than sperm retrieval with in vitro fertilization and intracytoplasmic sperm injection if the obstructive interval is less than 15 years and no female fertility risk factors are present. If epididymal obstruction is detected or advanced female age is present, the decision to use either microsurgical reconstruction or sperm retrieval with in vitro fertilization and intracytoplasmic sperm injection should be individualized. Sperm retrieval with in vitro fertilization and intracytoplasmic sperm injection is preferred to surgical treatment when female factors requiring in vitro fertilization are present or when the chance for success with sperm retrieval and intracytoplasmic sperm injection exceeds the chance for success with surgical treatment.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"312-5"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypophosphatemia in critically ill children.","authors":"Fernanda Souza de Menezes,&nbsp;Heitor Pons Leite,&nbsp;Juliana Fernandez,&nbsp;Silvana Gomes Benzecry,&nbsp;Werther Brunow de Carvalho","doi":"10.1590/s0041-87812004000500015","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500015","url":null,"abstract":"<p><p>The purpose of this paper is to review clinical studies on hypophosphatemia in pediatric intensive care unit patients with a view to verifying prevalence and risk factors associated with this disorder. We searched the computerized bibliographic databases Medline, Embase, Cochrane Library, and LILACS to identify eligible studies. Search terms included critically ill, pediatric intensive care, trauma, sepsis, infectious diseases, malnutrition, inflammatory response, surgery, starvation, respiratory failure, diuretic, steroid, antiacid therapy, mechanical ventilation. The search period covered those clinical trials published from January 1990 to January 2004. Studies concerning endocrinological disorders, genetic syndromes, rickets, renal diseases, anorexia nervosa, alcohol abuse, and prematurity were not included in this review. Out of 27 studies retrieved, only 8 involved pediatric patients, and most of these were case reports. One clinical trial and one retrospective study were identified. The prevalence of hypophosphatemia exceeded 50%. The commonly associated factors in most patients with hypophosphatemia were refeeding syndrome, malnutrition, sepsis, trauma, and diuretic and steroid therapy. Given the high prevalence, clinical manifestations, and multiple risk factors, the early identification of this disorder in critically ill children is crucial for adequate replacement therapy and also to avoid complications.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"306-11"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Induction of experimental mammary carcinogenesis in rats with 7,12-dimethylbenz(a)anthracene.","authors":"Alfredo Carlos S D Barros,&nbsp;Elisa Naomi K Muranaka,&nbsp;Lincon Jo Mori,&nbsp;Christina Helena T Pelizon,&nbsp;Kyoshi Iriya,&nbsp;Giovana Giocondo,&nbsp;José Aristodemo Pinotti","doi":"10.1590/s0041-87812004000500006","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500006","url":null,"abstract":"<p><strong>Purpose: </strong>To test an experimental model of chemical mammary carcinogenesis induction in rats.</p><p><strong>Methods: </strong>Twenty young virgin Sprague-Dawley female rats, aged 47 days, received 20 mg of 7,12-dimethylbenz(a)anthracene (DMBA) intragastrically by gavage. Afterwards, at 8 and 13 weeks, their mammary glands were examined. At the end of the experiment, the animals were sacrificed, and the mammary tumors were measured and weighed. Tumor fragments were analyzed using light microscopy.</p><p><strong>Results: </strong>Eight weeks after DMBA injection, 16 rats presented at least 1 breast tumor (80%). After 13 weeks, all of them (100%) developed breast carcinomas that were confirmed by histopathological analysis.</p><p><strong>Conclusion: </strong>This experimental animal model of chemical mammary induced carcinogenesis is feasible and can be used in further experiments on the role of tumorigenic biomodulator substances.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"257-61"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000500006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Glycemia in newborns of hypertensive mothers according to maternal treatment.","authors":"Silvana Darcie,&nbsp;Cléa R Leone,&nbsp;Valdenise M L T Calil,&nbsp;Elizete P Prescinotti,&nbsp;Soubhi Kahhale,&nbsp;Marcelo Zugaib","doi":"10.1590/s0041-87812004000500004","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500004","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the evolution of glycemic levels in newborns of hypertensive mothers according to maternal treatment.</p><p><strong>Methods: </strong>Prospective randomized study, including 93 newborns of mothers treated with isradipine (n = 39), atenolol (n = 40), or low sodium diet (control group - n=14). Glycemia was determined at birth (mother and newborn by the oxidase glucose method) and in the 1st, 3rd, 6th, 12th, and 24th hours after birth (newborn by a test strip method). The evolution of glycemia was analyzed in each group (Friedman test). The groups were compared regarding glycemia (Kruskall-Wallis test), and linear regression models were constructed for the analyses (independent variable = maternal glycemia; dependent variables = umbilical cord, 3rd, and 6th hour glycemia).</p><p><strong>Results: </strong>There were no statistically significant differences among the mean blood glucose levels of the 3 groups in any of the assessments. There was a correlation between maternal and umbilical cord blood glucose in the isradipine (r = 0.61; P <.05) and control (r = 0.84; P <.05) groups. Regarding glycemia levels of the mothers and newborns in the third and sixth hours postpartum, this correlation was present only in the control group (maternal x third hour: r = 0.65; P <.05; maternal x sixth hour: r = 0.68; P <.05). There were no correlations in the atenolol group. Hypoglycemia was detected in 51.3% of the isradipine group, 60% of the atenolol group, and 35.7% of the control group, and it was more frequent in the first hour postpartum in all groups.</p><p><strong>Conclusions: </strong>The results suggest a similar effect of the 3 types of treatment upon newborn glycemia. The correlation analysis suggests that isradipine could have effects upon newborn glycemia only after birth (correlation only in umbilical cord blood), whereas atenolol could act earlier (there was no correlation at any moment). The results also point to the need for glycemic control from the first hour postpartum of newborns of hypertensive mothers whether they have or have not undergone treatment with antihypertensive drugs.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"244-50"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anorectal leiomyomas: report of two cases with different anatomical patterns and literature review.","authors":"Fábio Guilherme Campos,&nbsp;Andrea Furlan Leite,&nbsp;Sérgio Eduardo Alonso Araújo,&nbsp;Fábio César Atuí,&nbsp;Vítor Seid,&nbsp;Angelita Habr-Gama,&nbsp;Desidério Roberto Kiss,&nbsp;Joaquim Gama-Rodrigues","doi":"10.1590/s0041-87812004000500013","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500013","url":null,"abstract":"<p><p>Gastrointestinal mesenchymal tumors comprise a rare group of gastrointestinal tract wall tumors that have long been a source of confusion and controversy, especially in terms of pathological classification, preoperative diagnosis, management strategies, and prognosis. This report describes the clinical manifestations and management of 2 rectal leiomyomas and reviews the pertinent literature. Case 1: A 44-year-old woman was admitted reporting a nodule in the right para-anal region for the previous 2 years. At proctological examination, a 4-cm diameter fibrous mass situated in the para-anal region that produced an arch under the smooth muscle on the right rectal wall just above the anorectal ring was noted. Computed tomography and magnetic resonance imaging of the abdomen and pelvis showed the lesion and detected no other abnormalities. Surgical treatment consisted of wide local resection of the tumor through a para-anal incision, with no attempts to perform lymphadenectomy. Case 2: A 40-year-old male patient was admitted reporting constant anal pain for 4 months. He presented a 3-cm submucosal nodule at the anterior rectal wall just above the dentate line. After 2 inconclusive preoperative biopsies, transanal resection of the tumor was performed. Histological analysis of the specimen showed a benign leiomyoma. A review of the literature is presented, emphasizing some clinical and therapeutic aspects of this unusual rectal tumor.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"296-301"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000500013","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effect of intravenous zoledronic acid on glucocorticoid-induced multiple vertebral fractures in juvenile systemic lupus erythematosus.","authors":"Sonia Cristina de Magalhães Souza,&nbsp;Claudia Tereza Lobato Borges,&nbsp;Vanda Jorgetti,&nbsp;Rosa Maria Rodrigues Pereira","doi":"10.1590/s0041-87812004000500014","DOIUrl":"https://doi.org/10.1590/s0041-87812004000500014","url":null,"abstract":"<p><p>Glucocorticoids are widely used in the treatment of lupus patients, and adverse effects, which include osteoporosis and associated fractures, are frequent. Treatment of osteoporosis of young patients should be effective and not harmful to bone growth and remodeling. Bisphosphonates are drugs that decrease the incidence of bone fractures, but their use in juvenile patients is still controversial because of their possible side effects on the growing skeleton. However, recently published studies showed that linear growth continued normally after treatment with these drugs, and there was no excessive suppression of bone remodeling or mineralization defects. Zoledronic acid is a new intravenous bisphosphonate that has been approved by the US FDA for use with hypercalcemia of malignancies and might be an effective treatment for postmenopausal osteoporosis. The authors report a case of a young girl with systemic lupus who developed multiple vertebral collapses due to glucocorticoid therapy, and zoledronic acid was used producing significant clinical and densitometric improvement.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 5","pages":"302-5"},"PeriodicalIF":0.0,"publicationDate":"2004-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000500014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24812641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hepatitis B: epidemiological, immunological, and serological considerations emphasizing mutation.","authors":"Marcelo El Khouri,&nbsp;Vera Aparecida dos Santos","doi":"10.1590/s0041-87812004000400011","DOIUrl":"https://doi.org/10.1590/s0041-87812004000400011","url":null,"abstract":"<p><p>The global prevalence of hepatitis B virus is estimated to be 350 million chronic carriers, varying widely from low (<2%, as in Western Europe, North America, New Zealand, Australia, and Japan) to high (>8% as in Africa, Southeast Asia, and China). The overall prevalence in Brazil is about 8%. There are currently 7 genotypic variations, from A to G, and also 4 main surface antigen subtypes: adw, ayw, adr, and ayr. There has been great interest in identifying the geographic distribution and prognosis associated with the various genotypes and subtypes. Although the serologic test is highly sensitive and specific, it does not detect cases of mutant hepatitis B, which is increasingly common worldwide due to resistance and vaccine escape, antiviral therapy, and immunosuppression, among other causes. Alterations in surface, polymerase, X region, core, and precore genes have been described. The main mutations occur in surface and in core/precore genes, also known as occult hepatitis, since its serologic markers of active infection (HBsAg) and viral replication (HBeAg) can be negative. Thus, mutation should be suspected when serologic tests to hepatitis B show control of immunity or replication coincident with worsened clinical status and exclusion of other causes of hepatitis.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 4","pages":"216-24"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000400011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24677070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Finasteride-associated male infertility.","authors":"Sidney Glina,&nbsp;Paulo Augusto Neves,&nbsp;Ricardo Saade,&nbsp;Nelson Rodrigues Netto,&nbsp;Jonathas Borges Soares,&nbsp;Andrea Giannotti Galuppo","doi":"10.1590/s0041-87812004000400009","DOIUrl":"https://doi.org/10.1590/s0041-87812004000400009","url":null,"abstract":"<p><p>Finasteride is a potent and specific inhibitor of the 5alpha-reductase enzyme in men. Clinical studies have shown that finasteride 1mg/day is effective for promoting hair growth in men with male pattern hair loss. However, there is a concern about the use of finasteride, especially in young fertile patients, because of its action on testosterone metabolism. This paper describes 3 cases of young patients who had very poor seminal quality during finasteride treatment (1 mg/day), and their seminal quality greatly improved after cessation of finasteride treatment. Two of them presented with a left varicocele and the other was obese. We hypothesize that finasteride may not dramatically change the spermatogenesis process in healthy men, but in patients with conditions related to infertility, an amplification of the negative influence of finasteride could occur. Future studies should be done to clarify the extent of the effect of finasteride in patients fertility problems.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 4","pages":"203-5"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000400009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24678310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Voiding dysfunction and urodynamic abnormalities in elderly patients.","authors":"Cristiano M Gomes,&nbsp;Sami Arap,&nbsp;Flávio E Trigo-Rocha","doi":"10.1590/s0041-87812004000400010","DOIUrl":"https://doi.org/10.1590/s0041-87812004000400010","url":null,"abstract":"<p><p>Lower urinary tract dysfunction is a major cause of morbidity and decreased quality of life in elderly men and women. With the progressive aging of the population, it is important to understand common micturitional disorders that may occur in this population. Most urinary problems in the elderly are multifactorial in origin, demanding a comprehensive assessment of the lower urinary tract organs, functional impairments, and concurrent medical diseases. Urodynamics is a highly valuable tool in the investigation of elderly patients with lower urinary tract symptoms. Urodynamic tests are not always necessary, being indicated after excluding potentially reversible conditions outside the urinary tract that may be causing or contributing to the symptoms. Although urodynamic tests may reveal common diagnoses such as bladder outlet obstruction and stress urinary incontinence in the elderly population, findings such as detrusor overactivity and impaired detrusor contractility are common and have important prognostic and therapeutic implications. The purpose of this article is to describe common urologic problems in the elderly and review the indications for and clinical aspects of urodynamic studies in these conditions.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 4","pages":"206-15"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1590/s0041-87812004000400010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24678311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical treatment of rectal prolapse: experience and late results with 51 patients.","authors":"Carlos Walter Sobrado,&nbsp;Desidério Roberto Kiss,&nbsp;Sérgio C Nahas,&nbsp;Sérgio E A Araújo,&nbsp;Victor E Seid,&nbsp;Guilherme Cotti,&nbsp;Angelita Habr-Gama","doi":"10.1590/s0041-87812004000400003","DOIUrl":"https://doi.org/10.1590/s0041-87812004000400003","url":null,"abstract":"<p><strong>Unlabelled: </strong>The \"best\" surgical technique for the management of complete rectal prolapse remains unknown. Due to its low incidence, it is very difficult to achieve a representative number of cases, and there are no large prospective randomized trials to attest to the superiority of one operation over another.</p><p><strong>Purpose: </strong>Analyze the results of surgical treatment of complete rectal prolapse during 1980 and 2002.</p><p><strong>Method: </strong>Retrospective study.</p><p><strong>Results: </strong>Fifty-one patients underwent surgical treatment during this period. The mean age was 56.7 years, with 39 females. Besides the prolapse itself, 33 patients complained of mucous discharge, 31 of fecal incontinence, 14 of constipation, 17 of rectal bleeding, and 3 of urinary incontinence. Abdominal operations were performed in 36 (71%) cases. Presacral rectopexy was the most common abdominal procedure (29 cases) followed by presacral rectopexy associated with sigmoidectomy (5 cases). The most common perineal procedure was perineal rectosigmoidectomy associated with levatorplasty (12 cases). Intraoperative bleeding from the presacral space developed in 2 cases, and a rectovaginal fistula occurred in another patient after a perineal rectosigmoidectomy. There were 2 recurrences after a mean follow-up of 49 months, which were treated by reoperation.</p><p><strong>Conclusion: </strong>Abdominal and perineal procedures can be used to manage complete rectal prolapse with safety and good long-term results. Age, associated medical conditions, and symptoms of fecal incontinence or constipation are the main features that one should bear in mind in order to choose the best surgical approach.</p>","PeriodicalId":76453,"journal":{"name":"Revista do Hospital das Clinicas","volume":"59 4","pages":"168-71"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"24678304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}